These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19139445)

  • 41. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthy colon, healthy life: a novel colorectal cancer screening intervention.
    Walsh JM; Salazar R; Nguyen TT; Kaplan C; Nguyen LK; Hwang J; McPhee SJ; Pasick RJ
    Am J Prev Med; 2010 Jul; 39(1):1-14. PubMed ID: 20547275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact on healthcare resources of switch from fecal occult blood test to fecal immunochemical test within the English Bowel Cancer Screening Program: a single-center study.
    Pelitari S; Gautham A; Mistry P; Mohan S; Brookes M; McKaig B; Shah A; Jewes S; Fieldhouse G; Veitch A; Murugananthan A
    Gastrointest Endosc; 2021 Sep; 94(3):598-606. PubMed ID: 33727015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Out-of-Pocket Cost Removal Intervention on Fecal Occult Blood Test Attendance.
    Tabuchi T; Murayama H; Hoshino T; Nakayama T
    Am J Prev Med; 2017 Aug; 53(2):e51-e62. PubMed ID: 28236518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
    Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
    Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Financial incentives for completion of fecal occult blood tests among veterans: a 2-stage, pragmatic, cluster, randomized, controlled trial.
    Kullgren JT; Dicks TN; Fu X; Richardson D; Tzanis GL; Tobi M; Marcus SC
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S35-43. PubMed ID: 25402401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Participation in colorectal cancer screening: a review.
    Vernon SW
    J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of self-reports of fecal occult blood tests and test results among individuals in the carpentry trade.
    Lipkus IM; Samsa GP; Dement J; Skinner CS; Green LS; Pompeii L; Ransohoff DF
    Prev Med; 2003 Nov; 37(5):513-9. PubMed ID: 14572436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
    Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
    Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S; Crow G;
    BMC Cancer; 2014 Apr; 14():263. PubMed ID: 24739235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.